SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-19-000013
Filing Date
2019-01-02
Accepted
2019-01-02 18:03:06
Documents
1
Period of Report
2018-12-28

Document Format Files

Seq Description Document Type Size
1 form4-01022019_030151.html 4  
1 form4-01022019_030151.xml 4 3965
  Complete submission text file 0001415889-19-000013.txt   5396
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address
BORKOWSKI EDWARD (Reporting) CIK: 0001197542 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37853 | Film No.: 19502977

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1